{"date":"2026-02-25","count":69,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6518-2026-02-25-2035-1ls3ha4","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2026-02-25","time":"20:35:50","subject":"本公司董事會通過新設置公司治理主管任命案","clause":"第11款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2026-02-25 20:35，「本公司董事會通過新設置公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-02-25-2016-1h5wa8w","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"20:16:49","subject":"本公司腸道微生態Symbiota系列產品Heat-treatedsoyabean fermentate獲得歐盟市場合法准入許可","clause":"第53款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-02-25 20:16，「本公司腸道微生態Symbiota系列產品Heat-treatedsoyabean fermentate獲得歐盟市場合法准」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-02-25-2000-1v3jfy1","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"20:00:40","subject":"公告114年度合併財務報告董事會預計召開日期為115年3月5日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-02-25 20:00，「公告114年度合併財務報告董事會預計召開日期為115年3月5日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-02-25-1911-2npiwu","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"19:11:36","subject":"董事會決議114年度股利分派(更正年度)","clause":"第14款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-02-25 19:11，「董事會決議114年度股利分派(更正年度)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-02-25-1906-fmyois","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"19:06:33","subject":"公告本公司董事會決議召開115年股東常會(更正主旨年度)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-02-25 19:06，「公告本公司董事會決議召開115年股東常會(更正主旨年度)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-02-25-1849-1vxn1ng","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"18:49:16","subject":"公告本公司董事會決議不分派114年度員工酬勞及董監事酬勞","clause":"第14款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-02-25 18:49，「公告本公司董事會決議不分派114年度員工酬勞及董監事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-02-25-1848-11b1948","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"18:48:07","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-02-25 18:48，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-02-25-1846-zjy883","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"18:46:50","subject":"董事會決議115年股利分派","clause":"第14款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-02-25 18:46，「董事會決議115年股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-02-25-1846-nq3yxb","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"18:46:39","subject":"公告本公司董事會決議不分派114年度員工酬勞及董事酬勞","clause":"第53款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-02-25 18:46，「公告本公司董事會決議不分派114年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-02-25-1844-1jhewlf","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"18:44:40","subject":"公告本公司公司治理主管異動","clause":"第8款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-02-25 18:44，「公告本公司公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2026-02-25-1839-11wjw0o","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"18:39:38","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：進階（3118），2026-02-25 18:39，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-02-25-1836-d9crff","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"18:36:18","subject":"公告本公司董事會通過114年度個體暨合併財務報告","clause":"第31款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-02-25 18:36，「公告本公司董事會通過114年度個體暨合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-02-25-1835-1pb8ufa","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"18:35:37","subject":"公告本公司董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-02-25 18:35，「公告本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-02-25-1829-y7gzxf","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"18:29:18","subject":"公告本公司董事會決議通過115年度對財團法人弘廬基金會之捐贈案","clause":"第43款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-02-25 18:29，「公告本公司董事會決議通過115年度對財團法人弘廬基金會之捐贈案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-02-25-1827-11b1948","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"18:27:57","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-02-25 18:27，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-02-25-1826-ng7zih","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"18:26:20","subject":"公告本公司董事會決議擬辦理115年第一次私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-02-25 18:26，「公告本公司董事會決議擬辦理115年第一次私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2026-02-25-1818-1howjn","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"18:18:24","subject":"公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：進階（3118），2026-02-25 18:18，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-02-25-1815-1bkm0mx","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"18:15:02","subject":"公告本公司代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-02-25 18:15，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-02-25-1814-1783swi","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"18:14:02","subject":"公告本公司114年度財務報告董事會預計召開日期為115年03月05日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-02-25 18:14，「公告本公司114年度財務報告董事會預計召開日期為115年03月05日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-02-25-1806-1aksbww","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"18:06:36","subject":"公告本公司114年度個體暨合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-02-25 18:06，「公告本公司114年度個體暨合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-02-25-1804-1kzq46c","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"18:04:08","subject":"公告本公司董事會決議不繼續辦理114年股東常會通過之私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-02-25 18:04，「公告本公司董事會決議不繼續辦理114年股東常會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-02-25-1803-1p917js","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"18:03:10","subject":"公告本公司董事會決議通過114年第四季合併財務報告","clause":"第31款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-02-25 18:03，「公告本公司董事會決議通過114年第四季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-02-25-1801-f7zdi0","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"18:01:51","subject":"公告本公司114年度財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-02-25 18:01，「公告本公司114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2026-02-25-1759-1mnbu64","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"17:59:12","subject":"公告本公司董事會重要決議","clause":"第53款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：進階（3118），2026-02-25 17:59，「公告本公司董事會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-02-25-1758-pzlxbc","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"17:58:38","subject":"公告本公司董事會擬議虧損撥補案暨不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-02-25 17:58，「公告本公司董事會擬議虧損撥補案暨不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-02-25-1752-drgvb6","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"17:52:59","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-02-25 17:52，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-02-25-1750-1b89la1","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"17:50:52","subject":"公告本公司董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-02-25 17:50，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-02-25-1737-k30ghg","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"17:37:14","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月5日","clause":"第31款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-02-25 17:37，「公告本公司114年度財務報告董事會預計召開日期為115年3月5日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-02-25-1735-1tookhr","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"17:35:05","subject":"中裕新藥確認Trogarzo對美出口維持「0關稅」，未受美國第122條關稅措施影響","clause":"第53款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-02-25 17:35，「中裕新藥確認Trogarzo對美出口維持「0關稅」，未受美國第122條關稅措施影響」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2026-02-25-1721-h38207","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2026-02-25","time":"17:21:30","subject":"本公司董事會決議股利分配","clause":"第31款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2026-02-25 17:21，「本公司董事會決議股利分配」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2026-02-25-1717-fqsc9p","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2026-02-25","time":"17:17:30","subject":"本公司董事會決議召開115年股東常會","clause":"第32款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2026-02-25 17:17，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-02-25-1715-1072y44","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"17:15:46","subject":"公告本公司民國114年度財務報告董事會預計召開日期為115年3月5日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-02-25 17:15，「公告本公司民國114年度財務報告董事會預計召開日期為115年3月5日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-02-25-1709-1mvy42n","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"17:09:13","subject":"公告本公司董事會決議股利分派情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-02-25 17:09，「公告本公司董事會決議股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-02-25-1708-e6hr0k","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"17:08:49","subject":"公告本公司董事會通過114年度合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-02-25 17:08，「公告本公司董事會通過114年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-02-25-1708-1dorvzb","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"17:08:20","subject":"公告本公司民國114年度第4季合併財務報告之董事會預計召開日期為115年03月05日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-02-25 17:08，「公告本公司民國114年度第4季合併財務報告之董事會預計召開日期為115年03月05日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-02-25-1708-11b1948","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"17:08:17","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-02-25 17:08，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-02-25-1707-1j4vmqb","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"17:07:52","subject":"公告本公司董事會決議授權董事長購置土地暨廠房","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-02-25 17:07，「公告本公司董事會決議授權董事長購置土地暨廠房」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2026-02-25-1702-1b89la1","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"17:02:40","subject":"公告本公司董事會通過114年度財務報告","clause":"第31款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：進階（3118），2026-02-25 17:02，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2026-02-25-1701-5j9yh6","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2026-02-25","time":"17:01:26","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2026-02-25 17:01，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2026-02-25-1700-4zt7m7","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2026-02-25","time":"17:00:55","subject":"本公司董事會通過會計主管任命案","clause":"第11款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2026-02-25 17:00，「本公司董事會通過會計主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-02-25-1656-xsp9n5","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-02-25","time":"16:56:34","subject":"公告本公司董事會決議現金增資發行新股案","clause":"第9款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-02-25 16:56，「公告本公司董事會決議現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-02-25-1656-bhuso3","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-02-25","time":"16:56:06","subject":"公告本公司董事會通過114年財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-02-25 16:56，「公告本公司董事會通過114年財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-02-25-1653-stqcym","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"16:53:48","subject":"公告本公司115年1月份自結應收帳款餘額及回收情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-02-25 16:53，「公告本公司115年1月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-02-25-1646-11r8ft9","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"16:46:17","subject":"本公司董事會決議召開民國115年股東常會","clause":"第17款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-02-25 16:46，「本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-02-25-1639-1czgixf","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"16:39:09","subject":"董事會決議無股利分派","clause":"第14款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-02-25 16:39，「董事會決議無股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-02-25-1636-1mm5523","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"16:36:12","subject":"公告本公司董事會決議召開115年股東常會事宜(更正9.召集事由五)","clause":"第17款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-02-25 16:36，「公告本公司董事會決議召開115年股東常會事宜(更正9.召集事由五)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-02-25-1635-1kyvyp8","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-02-25","time":"16:35:27","subject":"公告本公司「用以遞送護理藥劑的牙套 METHOD OF PREPARINGA MEDICAMENT DELIVERY TOOTH COVERING」取得美國發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-02-25 16:35，「公告本公司「用以遞送護理藥劑的牙套 METHOD OF PREPARINGA MEDICAMENT DELIVERY T」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-02-25-1612-1dd9qx8","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"16:12:41","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"第17款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-02-25 16:12，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-02-25-1608-xppugo","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"16:08:35","subject":"董事會決議發行員工認股權憑證公告","clause":"第11款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-02-25 16:08，「董事會決議發行員工認股權憑證公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2026-02-25-1606-1hds7fq","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"16:06:57","subject":"公告本公司董事會通過114年第四季合併財務報告","clause":"第31款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2026-02-25 16:06，「公告本公司董事會通過114年第四季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-02-25-1603-iyfauy","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"16:03:06","subject":"公告本公司國內第一次有擔保轉換公司債委託代收價款行庫及存儲專戶行庫","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-02-25 16:03，「公告本公司國內第一次有擔保轉換公司債委託代收價款行庫及存儲專戶行庫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-02-25-1602-3kb7gv","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"16:02:10","subject":"本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-02-25 16:02，「本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-02-25-1559-1obukju","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"15:59:04","subject":"公告本公司114年第四季合併財務報告董事會之預計召開日期為115年3月5日。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-02-25 15:59，「公告本公司114年第四季合併財務報告董事會之預計召開日期為115年3月5日。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-02-25-1555-wn4o24","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"15:55:57","subject":"代重要子公司意能生技(股)公司公告董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-02-25 15:55，「代重要子公司意能生技(股)公司公告董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-02-25-1553-13hg1o","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"15:53:53","subject":"本公司董事會通過召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-02-25 15:53，「本公司董事會通過召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-02-25-1550-drgvb6","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"15:50:47","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-02-25 15:50，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-02-25-1548-1j1lzo6","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"15:48:52","subject":"本公司董事會決議通過114年合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-02-25 15:48，「本公司董事會決議通過114年合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-02-25-1548-s01yzr","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"15:48:34","subject":"代重要子公司意能生技(股)公司公告董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-02-25 15:48，「代重要子公司意能生技(股)公司公告董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-02-25-1548-1nxb0oo","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"15:48:01","subject":"因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-02-25 15:48，「因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-02-25-1547-1b89la1","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"15:47:14","subject":"公告本公司董事會通過114年度財務報告","clause":"第31款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-02-25 15:47，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-02-25-1543-11wjw0o","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"15:43:04","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-02-25 15:43，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-02-25-1541-1n0b4kh","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"15:41:41","subject":"公告本公司董事會決議通過不發放114年度員工酬勞及董事酬勞","clause":"第51款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-02-25 15:41，「公告本公司董事會決議通過不發放114年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-02-25-1536-6qm4c7","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"15:36:19","subject":"代重要子公司益興生醫(股)公司公告董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-02-25 15:36，「代重要子公司益興生醫(股)公司公告董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-02-25-1525-190muy8","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"15:25:22","subject":"公告本公司114年第四季財務報告董事會召開日期為115年3月5日","clause":"第31款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-02-25 15:25，「公告本公司114年第四季財務報告董事會召開日期為115年3月5日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-02-25-1524-yww2gu","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"15:24:34","subject":"代重要子公司益興生醫(股)公司公告董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-02-25 15:24，「代重要子公司益興生醫(股)公司公告董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-02-25-1447-k30ghg","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"14:47:52","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月5日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-02-25 14:47，「公告本公司114年度財務報告董事會預計召開日期為115年3月5日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-02-25-1421-1e7utwn","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"14:21:19","subject":"公告本公司114年度合併財務報告董事會預計召開日期為115年3月5日","clause":"第31款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-02-25 14:21，「公告本公司114年度合併財務報告董事會預計召開日期為115年3月5日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2026-02-25-1415-f7zdi0","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2026-02-25","time":"14:15:25","subject":"公告本公司114年度財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：德英（4911），2026-02-25 14:15，「公告本公司114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-02-25-1359-gk7gzj","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-02-25","time":"13:59:35","subject":"公告本公司114年財務合併報告董事會預計召開日期為115年3月5日。","clause":"第31款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-02-25 13:59，「公告本公司114年財務合併報告董事會預計召開日期為115年3月5日。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}